<DOC>
	<DOCNO>NCT02466789</DOCNO>
	<brief_summary>The purpose study improve investigator ability diagnose von Willebrand Disease ( VWD ) , common inherit bleeding disorder . This study look new screen blood test use determine person VWD . This new screen blood test determine diagnosis rapidly current blood test . Also test could available local hospital lab rather require sample send big specialized lab .</brief_summary>
	<brief_title>Investigating Von Willebrand Factor ( VWF ) Functional Screening Assay Assigning Phenotypic Variants Von Willebrand Disease ( VWD )</brief_title>
	<detailed_description>This investigation prospective , multicenter trial validate clinical utility novel screen assay diagnostic screen assay VWD variant : Type 1C , 2A , 2B , 2M 2N . Once subject enrol study , minimum 0.5ml citrate plasma collect analyzed Bleeding Clotting Disorders Institute Laboratory Peoria Illinois . Results collect : phenotype function profile determine , statistically analyze compare qualitative data Blood Center Wisconsin . Data expect correlate previously show prior study confirm utility assay .</detailed_description>
	<mesh_term>Von Willebrand Diseases</mesh_term>
	<criteria>New subject undergoing evaluation diagnosis VWD determine VWF : Ag VWF : RCo &lt; 50 IU/dl VWF : RCo/VWF : Ag &lt; 0.7 . Also subject include Type 2 N VWD clinically suspect Those subject whose lab result meet inclusion criterion</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Bleeding Disorder , inherit</keyword>
	<keyword>Von Willebrands Disease</keyword>
	<keyword>Hematologic Test</keyword>
	<keyword>VWF</keyword>
	<keyword>VWD</keyword>
</DOC>